A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Completed · Phase 3 · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) versus placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder (MDD).

Key facts

Study ID

NCT01371734

Run by

Pfizer

People needed

363

Starts

2011-08-01

Expected to finish

2015-09-01

Last updated by the study team

2017-03-20

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >=7 and <18 years of age
• Primary diagnosis of major depressive disorder (MDD)
• CDRS-R score >40

You may not qualify if…

• History of suicidal behavior or requires precaution against suicide
• Not in generally healthy medical condition
• History of psychosis or bipolar disorder
• Seizure disorder

Where it is running

• Children's Hospital of Alabama Laboratory — Birmingham, Alabama, United States
• The University of Alabama at Birmingham, Office of Psychiatric Research — Birmingham, Alabama, United States
• Center for Advanced Improvement — Tucson, Arizona, United States
• Sun Valley Research Center — Imperial, California, United States
• MCB Clinical Research Centers — Colorado Springs, Colorado, United States
• Bliss Basement Pharmacy - Hartford Hospital — Hartford, Connecticut, United States
• Institute of Living/Hartford Hospital — Hartford, Connecticut, United States
• Institute of Living — Hartford, Connecticut, United States
• SJS Clinical Research, Inc. — Destin, Florida, United States
• Sarkis Clinical Trials — Gainesville, Florida, United States
• Clinical Neuroscience Solutions — Jacksonville, Florida, United States
• Medical Research Group of Central Florida — Orange City, Florida, United States
• Millenia Psychiatry & Research, Inc. — Orlando, Florida, United States
• Janus Center for Psychiatric Research — West Palm Beach, Florida, United States
• Northwest Behavioral Research Center — Marietta, Georgia, United States
• Capstone Clinical Research — Libertyville, Illinois, United States
• AMR-Baber Research Inc. — Naperville, Illinois, United States
• Clinco — Terre Haute, Indiana, United States
• Louisiana State University Health Sciences Center-Psychopharmacology Research Clinic — Shreveport, Louisiana, United States
• Drug:University Health Shreveport Outpatient — Shreveport, Louisiana, United States
• Pharmasite Research Inc — Baltimore, Maryland, United States
• Millennium Psychiatric Associates, LLC — Creve Coeur, Missouri, United States
• Premier Psychiatric Research Institute, LLC — Lincoln, Nebraska, United States
• Erie County Medical Center / State University of New York at Buffalo affiliate — Buffalo, New York, United States
• The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System — Glen Oaks, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.